Home Investing We’re lowering our price target on Bristol Myers as two key overhangs persist

We’re lowering our price target on Bristol Myers as two key overhangs persist

by admin

Shares were down around 5% on Thursday afternoon despite a beat-and-raise quarter.

You may also like

Leave a Comment

twenty − 12 =